CA2474590A1 - Traitement de troubles fonctionnels sexuels masculins - Google Patents
Traitement de troubles fonctionnels sexuels masculins Download PDFInfo
- Publication number
- CA2474590A1 CA2474590A1 CA002474590A CA2474590A CA2474590A1 CA 2474590 A1 CA2474590 A1 CA 2474590A1 CA 002474590 A CA002474590 A CA 002474590A CA 2474590 A CA2474590 A CA 2474590A CA 2474590 A1 CA2474590 A1 CA 2474590A1
- Authority
- CA
- Canada
- Prior art keywords
- oxytocin
- selective
- receptors
- receptor
- vasopressin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
La présente invention concerne une composition comprenant un antagoniste d'ocytocine sélectif destiné au traitement et/ou à la prévention des troubles de l'éjaculation, dans lequel on mélange éventuellement un antagoniste d'ocytocine sélectif avec un porteur, un diluant ou un excipient répondant aux normes pharmaceutiques.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0202282.0A GB0202282D0 (en) | 2002-01-31 | 2002-01-31 | Treatment of male sexual dysfunction |
GB0202282.0 | 2002-01-31 | ||
PCT/IB2003/000140 WO2003064402A1 (fr) | 2002-01-31 | 2003-01-20 | Traitement de troubles fonctionnels sexuels masculins |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2474590A1 true CA2474590A1 (fr) | 2003-08-07 |
Family
ID=9930155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002474590A Abandoned CA2474590A1 (fr) | 2002-01-31 | 2003-01-20 | Traitement de troubles fonctionnels sexuels masculins |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1470115A1 (fr) |
JP (3) | JP2005525321A (fr) |
KR (2) | KR100829262B1 (fr) |
CN (1) | CN100500658C (fr) |
AU (1) | AU2003201471B2 (fr) |
BR (1) | BR0307337A (fr) |
CA (1) | CA2474590A1 (fr) |
GB (1) | GB0202282D0 (fr) |
HK (1) | HK1073109A1 (fr) |
IL (2) | IL162822A0 (fr) |
MX (1) | MXPA04007434A (fr) |
NZ (1) | NZ546408A (fr) |
PL (1) | PL371415A1 (fr) |
TW (1) | TW200302732A (fr) |
WO (1) | WO2003064402A1 (fr) |
ZA (1) | ZA200405208B (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3646871A1 (fr) * | 2018-10-30 | 2020-05-06 | SEROJAC PME Handels GmbH | Traitement et prévention de l'éjaculation précoce (pe) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9013750D0 (en) | 1990-06-20 | 1990-08-08 | Pfizer Ltd | Therapeutic agents |
GB9114760D0 (en) | 1991-07-09 | 1991-08-28 | Pfizer Ltd | Therapeutic agents |
GB9119704D0 (en) | 1991-09-14 | 1991-10-30 | Pfizer Ltd | Therapeutic agents |
GB9121028D0 (en) | 1991-10-03 | 1991-11-13 | Pfizer Ltd | Therapeutic agents |
GB9126260D0 (en) | 1991-12-11 | 1992-02-12 | Pfizer Ltd | Therapeutic agents |
GB9213623D0 (en) | 1992-06-26 | 1992-08-12 | Pfizer Ltd | Therapeutic agents |
GB9218322D0 (en) | 1992-08-28 | 1992-10-14 | Pfizer Ltd | Therapeutic agents |
CA2151821A1 (fr) * | 1992-12-23 | 1994-07-07 | Kevin Gilbert | Derives de substitution hydantoine et succinimide d'antagonistes de spiro-indanylcamphresulfonyle oxytocine |
CA2118756A1 (fr) * | 1993-03-12 | 1994-09-13 | Anthony M. Demarco | Methode de synthese de derives de substitution amidiques d'antagonistes de la piperizinylcamphresulfonyloxytocine |
GB0007884D0 (en) | 2000-03-31 | 2000-05-17 | Pfizer Ltd | Diphenyl ether compounds useful in therapy |
US20020028799A1 (en) * | 2000-07-06 | 2002-03-07 | Naylor Alasdair Mark | Treatment of male sexual dysfunction |
-
2002
- 2002-01-31 GB GBGB0202282.0A patent/GB0202282D0/en not_active Ceased
-
2003
- 2003-01-20 PL PL03371415A patent/PL371415A1/xx not_active Application Discontinuation
- 2003-01-20 CN CNB038030535A patent/CN100500658C/zh not_active Expired - Lifetime
- 2003-01-20 EP EP03700164A patent/EP1470115A1/fr not_active Withdrawn
- 2003-01-20 NZ NZ546408A patent/NZ546408A/en not_active IP Right Cessation
- 2003-01-20 BR BR0307337-8A patent/BR0307337A/pt not_active IP Right Cessation
- 2003-01-20 MX MXPA04007434A patent/MXPA04007434A/es active IP Right Grant
- 2003-01-20 CA CA002474590A patent/CA2474590A1/fr not_active Abandoned
- 2003-01-20 KR KR1020047011672A patent/KR100829262B1/ko not_active IP Right Cessation
- 2003-01-20 IL IL16282203A patent/IL162822A0/xx unknown
- 2003-01-20 WO PCT/IB2003/000140 patent/WO2003064402A1/fr active Application Filing
- 2003-01-20 JP JP2003564025A patent/JP2005525321A/ja not_active Ceased
- 2003-01-20 AU AU2003201471A patent/AU2003201471B2/en not_active Expired
- 2003-01-20 KR KR1020077029747A patent/KR20080011232A/ko not_active Application Discontinuation
- 2003-01-27 TW TW092101731A patent/TW200302732A/zh unknown
-
2004
- 2004-06-30 ZA ZA2004/05208A patent/ZA200405208B/en unknown
- 2004-07-01 IL IL162822A patent/IL162822A/en active IP Right Grant
-
2005
- 2005-07-11 HK HK05105801.3A patent/HK1073109A1/xx not_active IP Right Cessation
-
2010
- 2010-03-30 JP JP2010079241A patent/JP2010209075A/ja not_active Withdrawn
-
2013
- 2013-02-28 JP JP2013038357A patent/JP2013151511A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
TW200302732A (en) | 2003-08-16 |
KR20040079958A (ko) | 2004-09-16 |
HK1073109A1 (en) | 2005-09-23 |
GB0202282D0 (en) | 2002-03-20 |
ZA200405208B (en) | 2005-08-31 |
NZ546408A (en) | 2007-10-26 |
IL162822A (en) | 2010-11-30 |
CN1625553A (zh) | 2005-06-08 |
KR20080011232A (ko) | 2008-01-31 |
BR0307337A (pt) | 2004-12-07 |
JP2010209075A (ja) | 2010-09-24 |
JP2005525321A (ja) | 2005-08-25 |
IL162822A0 (en) | 2005-11-20 |
CN100500658C (zh) | 2009-06-17 |
KR100829262B1 (ko) | 2008-05-13 |
PL371415A1 (en) | 2005-06-13 |
JP2013151511A (ja) | 2013-08-08 |
EP1470115A1 (fr) | 2004-10-27 |
MXPA04007434A (es) | 2004-10-11 |
WO2003064402A1 (fr) | 2003-08-07 |
AU2003201471B2 (en) | 2009-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2004502735A (ja) | 男性の性機能障害の治療 | |
JP2005350482A (ja) | Fsdの処置のための化合物 | |
US20030119714A1 (en) | Treatment of male sexual dysfunction | |
JP2008266338A (ja) | 性機能障害を治療するための選択的ドーパミンd3受容体アゴニスト | |
US20150072995A1 (en) | Treatment of male sexual dysfunction | |
JP2004522720A (ja) | 雄性性的機能障害の処置 | |
AU2003201471B2 (en) | Treatment of male sexual dysfunction | |
AU2003201471A1 (en) | Treatment of male sexual dysfunction | |
JP2004517046A (ja) | 医薬 | |
US20040185094A1 (en) | Pharmaceutical | |
KR20030061441A (ko) | 남성 성기능 장애의 치료 | |
ZA200304460B (en) | Treatment of male sexual dysfunction. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |